Manufacturing Expertise Bispecific / Multispecific Antibodies
Bispecific and multispecific antibodies introduce structural complexity, chain-pairing challenges, and enhanced analytical demands. Avid supports these advanced formats through optimized mammalian expression systems, robust purification strategies, and manufacturing controls designed to manage complexity at scale.
Overview
Advancing Bispecific & Multispecific
Antibody Programs
Key Bispecific Development & Manufacturing Considerations
- Structural complexity and chain pairing
- Aggregation control
- Expression optimization
- Formulation development
- Advanced analytical characterization
- Robust and scalable purification strategies
How Avid Supports Bispecific Programs
- Platform-enabled development to accelerate complex programs
- Process optimization for complex formats
- Enhanced analytical characterization
- Clinical and commercial manufacturing
- Validated scale-up and lifecycle support
- Formulation development
Solutions
Explore Our Solutions
Learn More
Bispecific & Multispecific Antibody FAQs
Yes, when supported by optimized expression systems, robust process control and validated manufacturing infrastructure.
They require precise chain pairing and enhanced process controls to manage structural complexity and product consistency.
Advance Your Bispecific
Program with Confidence
Connect with our team to discuss development timelines, manufacturing strategy, and scalable CGMP production.